EyeSense
Latest round
- Series A
Last raised
- Jun 2005
Total raised
- $8.3M
Investors
- 5
About EyeSense
EyeSense GmbH is dedicated to creating innovative solutions for diabetes management through its advanced glucose monitoring technology. The company has evolved its strategy since its inception, specifically targeting diabetes patients across Europe.EyeSense specializes in advanced medical technology focused on continuous blood glucose monitoring for diabetics. The company's flagship product is a state-of-the-art optical sensor that provides precise and continuous measurement of glucose concentrations in subcutaneous interstitial fluid. Designed for a wear duration of up to four weeks, the sensor minimizes waste and lowers costs while ensuring user comfort through a pain-free monitoring experience. The EyeSense system facilitates discreet, wireless real-time monitoring, with immediate alerts for blood sugar fluctuations. The technology is expected to expand its capabilities beyond glucose monitoring to include a wide array of biometric data, such as ketones and cortisol, positioning EyeSense as a versatile health monitoring solution.EyeSense generates revenue through the sale of its innovative glucose monitoring products and related services. The primary business model includes direct-to-consumer transactions, where users purchase the sensor and subscription-based services that allow for ongoing monitoring and data management through the EyeSense app. This subscription model not only provides users with real-time health insights but also includes future software updates to enhance functionality. Customers engage in a structured pricing plan that encompasses the initial purchase of the sensor, followed by monthly or annual fees for app access and software enhancements. EyeSense is actively designing new products that will further diversify its health monitoring capabilities, with a focus on biometric data beyond glucose monitoring anticipated for release in the coming years. Specific regions targeted for expansion include additional markets within Europe, with plans to reach these markets by 2025.
Who invested in EyeSense
5 investors across 1 round
See all investors in EyeSense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2005
Amount
$8.3M
Investors
Questions about EyeSense
Who invested in EyeSense?
EyeSense has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EyeSense raised?
EyeSense has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EyeSense last raise money?
EyeSense's most recent round on record is a Series A, in Jun 2005.
What does EyeSense do?
EyeSense GmbH is dedicated to creating innovative solutions for diabetes management through its advanced glucose monitoring technology.
Where is EyeSense headquartered?
EyeSense is headquartered in Germany.
Which VCs invest in companies like EyeSense?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at EyeSense's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like EyeSense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.